These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 6545595)

  • 41. [Determination of average fiber density (single fiber lead), quantitative electromyography and serum CK in the detection of Duchenne carriers].
    Mamoli B; Toifl K; Vormittag W; Pateisky K
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1983 Mar; 14(1):36-8. PubMed ID: 6407816
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of age on the detection rate in Duchenne muscular dystrophy.
    Zatz M; Otto PA
    J Neurol Sci; 1980 Sep; 47(3):407-10. PubMed ID: 7420114
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Possibility of prenatal diagnosis of progressive muscular dystrophy: evaluation of creatine kinase activity in serum and the capping of lymphocytes].
    Venturoli A; Sensi A; Baricordi R; Artioli A; Osti L; Mari R; Ferroni G; Lucci M
    Boll Soc Ital Biol Sper; 1983 Dec; 59(12):1988-94. PubMed ID: 6608363
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Diagnosis of female carriers of Duchenne's progressive muscular dystrophy using discriminative analysis of various serum enzyme activities].
    Büsing CM; Heyck H; Laudahn G
    Klin Wochenschr; 1969 Oct; 47(20):1099-103. PubMed ID: 5381991
    [No Abstract]   [Full Text] [Related]  

  • 45. Serum creatine phosphokinase in the detection of carriers of Duchenne's muscular dystrophy in Northern Ireland.
    McCormick D; Allen IV
    Ulster Med J; 1976; 45(1):79-83. PubMed ID: 936362
    [No Abstract]   [Full Text] [Related]  

  • 46. Serum myoglobin in muscular dystrophy.
    Kagen LJ; Moussavi S; Miller SL; Tsairis P
    Muscle Nerve; 1980; 3(3):221-6. PubMed ID: 7374673
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diminished cap formation in lymphocytes from patients and carriers of Duchenne muscular dystrophy.
    Verrill HL; Pickard NA; Gruemer HD
    Clin Chem; 1977 Dec; 23(12):2341-3. PubMed ID: 923085
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum creatine kinase in the detection of Duchenne muscular dystrophy carriers: effects of season and multiple testing.
    Percy ME; Andrews DF; Thompson MW
    Muscle Nerve; 1982 Jan; 5(1):58-64. PubMed ID: 7057807
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Myoglobin RIA in detecting carriers of Duchenne's muscular dystrophy.
    Sabria-Leal M; Gimeno-Leal JM; Paret-Masana A; Rey-Joly Barroso C
    Eur Neurol; 1986; 25(4):253-5. PubMed ID: 3720800
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Studies of the carrier state in the Duchenne type of muscular dystrophy. I. Effect of exercise on serum creatine kinase activity.
    Hudgson P; Gardner-Medwin D; Pennington RJ; Walton JN
    J Neurol Neurosurg Psychiatry; 1967 Oct; 30(5):416-9. PubMed ID: 6062992
    [No Abstract]   [Full Text] [Related]  

  • 51. Detection of carriers of X-linked gene for Duchenne muscular dystrophy by levels of creatine kinase and pyruvate kinase.
    Falcão-Conceição DN; Gonçalves-Pimentel MM; Baptista ML; Ubatuba S
    J Neurol Sci; 1983 Dec; 62(1-3):171-80. PubMed ID: 6668472
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Letter: Follow-up study of serum-creatine-kinase in carriers of Duchenne muscular dystrophy.
    Moser H; Vogt J
    Lancet; 1974 Sep; 2(7881):661-2. PubMed ID: 4137773
    [No Abstract]   [Full Text] [Related]  

  • 53. Absence of correlation between skewed X inactivation in blood and serum creatine-kinase levels in Duchenne/Becker female carriers.
    Sumita DR; Vainzof M; Campiotto S; Cerqueira AM; Cánovas M; Otto PA; Passos-Bueno MR; Zatz M
    Am J Med Genet; 1998 Dec; 80(4):356-61. PubMed ID: 9856563
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Creatine kinase isoenzyme patterns in Duchenne muscular dystrophy.
    Goedde HW; Christ I; Benkmann HG; Beckmann R; Lang H
    Clin Genet; 1978 Nov; 14(5):257-60. PubMed ID: 709904
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Variability of serum creatine phosphokinase activity in normal women and carriers of the gene for Duchenne muscular dystrophy.
    Perry TB; Fraser FC
    Neurology; 1973 Dec; 23(12):1316-23. PubMed ID: 4796611
    [No Abstract]   [Full Text] [Related]  

  • 56. Detection of preclinical Duchenne muscular dystrophy and its female carriers.
    Beckmann R
    Isr J Med Sci; 1977 Feb; 13(2):102-6. PubMed ID: 863671
    [No Abstract]   [Full Text] [Related]  

  • 57. Myoglobinemia in Duchenne muscular dystrophy carriers.
    Ando T; Kato T; Ohsawa M; Fukuyama Y
    Brain Dev; 1980; 2(1):87-8. PubMed ID: 7416442
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Improved detection of Duchenne muscular dystrophy heterozygotes using discriminant analysis of creatine kinase levels.
    Muir WA; Knoke J; Martin A; Vignos P; McErlean A
    Am J Med Genet; 1983 Jan; 14(1):125-34. PubMed ID: 6829600
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The contribution of assays for lymphocyte capping and creatine kinase to detection of the Becker-type dystrophy trait.
    Goldsmith BM; Gruemer HD; Hawley RJ; Pickard NA; Verrill HL; Nance WE; Miller G; Crawford RG
    Clin Chem; 1980 May; 26(6):754-9. PubMed ID: 7371153
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A nearest neighbour decision rule for EMG detection of carriers of Duchenne muscular dystrophy.
    Hausmanowa-Petrusewicz I; Wierzbicka M; Jozwik A; Szmidt-Salkowska E; Borkowska J
    Electromyogr Clin Neurophysiol; 1982; 22(6):445-57. PubMed ID: 7140630
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.